Literature DB >> 25060249

Neutropenic fever.

Lindsey White1, Michael Ybarra2.   

Abstract

Fever is a common presenting complaint among adult or pediatric patients in the emergency department setting. Although fever in healthy individuals does not necessarily indicate severe illness, fever in patients with neutropenia may herald a life-threatening infection. Therefore, prompt recognition of patients with neutropenic fever is imperative. Serious bacterial illness is a significant cause of morbidity and mortality for neutropenic patients. Neutropenic fever should trigger the initiation of a rapid work-up and the administration of empiric systemic antibiotic therapy to attenuate or avoid the progression along the spectrum of sepsis, severe sepsis, septic shock syndrome, and death.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bacterial infection; Neutropenic fever; Risk stratification

Mesh:

Year:  2014        PMID: 25060249     DOI: 10.1016/j.emc.2014.04.002

Source DB:  PubMed          Journal:  Emerg Med Clin North Am        ISSN: 0733-8627            Impact factor:   2.264


  6 in total

1.  What is the role of leukopenia in the assessment of septic arthritis?

Authors:  Chelsea R Brown; Richard Samade; Daniel Lynch; John Mickley; Karilyn T M Larkin; Amy L Speeckaert
Journal:  J Orthop       Date:  2022-05-07

2.  The Comparison of The Efficacy and Safety of Original and Biosimilar Filgrastim in Prevention of Chemotherapy-Induced Neutropenia in Children with Cancer.

Authors:  Mustafa Buyukavci; Zuhal Keskin Yildirim
Journal:  Eurasian J Med       Date:  2019-06

3.  Serum Endocan Levels in Children with Febrile Neutropenia.

Authors:  Eylem Kiral; Ener Cagri Dinleyici; Ayse Bozkurt-Turhan; Ozcan Bor; Yurdanur Akgun; Necat Akdeniz Akgun
Journal:  Hematol Rep       Date:  2016-03-17

4.  The High Prevalence of Functional Complement Defects Induced by Chemotherapy.

Authors:  Mischa P Keizer; Angela M Kamp; Cathelijn Aarts; Judy Geisler; Huib N Caron; Marianne D van de Wetering; Diana Wouters; Taco W Kuijpers
Journal:  Front Immunol       Date:  2016-10-17       Impact factor: 7.561

5.  Management of Treatment-Related Infectious Complications in High-Risk Hemato-Oncological Patients via Telemedicine.

Authors:  Katarína Hradská; Tereza Popková; Michaela Skořupová; Jana Mihályová; Tomáš Jelínek; Jana Lančová; Norbert Schellong; Roman Hájek
Journal:  Cancer Manag Res       Date:  2022-05-04       Impact factor: 3.602

6.  Early discontinuation of antibiotics for febrile neutropenia versus continuation until neutropenia resolution in people with cancer.

Authors:  Anat Stern; Elena Carrara; Roni Bitterman; Dafna Yahav; Leonard Leibovici; Mical Paul
Journal:  Cochrane Database Syst Rev       Date:  2019-01-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.